Literature DB >> 809483

Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization.

R H Kenyon, C E Pedersen.   

Abstract

Rocky Mountain spotted fever vaccine was produced from rickettsiae grown in chicken embryo cells in roller bottle cultures. The rickettsiae were concentrated and purified by passage through a sucrose gradient and inactivated with formalin. This vaccine satisfactorily passed preinactivation and final container testing and is believed to be superior to the presently available yolk sac vaccine.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 809483      PMCID： PMC275168          DOI： 10.1128/jcm.1.6.500-503.1975

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Rickettsial diseases in the United States.

Authors:  T E WOODWARD
Journal:  Med Clin North Am       Date:  1959-09       Impact factor: 5.456

2.  Hemadsorption (adsorption-hemagglutination) test for viral agents in tissue culture with special reference to influenza.

Authors:  A SHELOKOV; J E VOGEL; L CHI
Journal:  Proc Soc Exp Biol Med       Date:  1958-04

3.  Public Health Weekly Reports for OCTOBER 9, 1925.

Authors: 
Journal:  Public Health Rep       Date:  1925-10-09       Impact factor: 2.792

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Immunization against scrub typhus. II. Preparation of lyophilized living vaccine.

Authors:  E B JACKSON; J E SMADEL
Journal:  Am J Hyg       Date:  1951-05

6.  Rocky Mountain spotted fever acquired in a laboratory.

Authors:  J E Johnson; P J Kadull
Journal:  N Engl J Med       Date:  1967-10-19       Impact factor: 91.245

7.  Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii.

Authors:  H L DuPont; R B Hornick; A T Dawkins; G G Heiner; I B Fabrikant; C L Wisseman; T E Woodward
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

8.  Method for counting Rickettsiae and Chlamydiae in purified suspensions.

Authors:  R Silberman; P Fiset
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

9.  Preparation of vaccines for Rocky Mountain spotted fever from rickettsiae propagated in cell culture.

Authors:  R H Kenyon; W M Acree; G G Wright; F W Melchior
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

10.  Rocky Mountain spotted fever. Laboratory infection in a vaccinated individual.

Authors:  F M Calia; P J Bartelloni; R W McKinney
Journal:  JAMA       Date:  1970-03-23       Impact factor: 56.272
  10 in total
  16 in total

1.  A recombinant Rickettsia conorii vaccine protects guinea pigs from experimental boutonneuse fever and Rocky Mountain spotted fever.

Authors:  S Vishwanath; G A McDonald; N G Watkins
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  Humoral immune response to Rocky Mountain spotted fever in experimentally infected guinea pigs: immunoprecipitation of lactoperoxidase 125I-labeled proteins and detection of soluble antigens of Rickettsia rickettsii.

Authors:  J C Williams; D H Walker; M G Peacock; S T Stewart
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

3.  Electron microscopic study on the interaction between normal guinea pig peritoneal macrophages and Coxiella burnetii.

Authors:  R A Kishimoto; B J Veltri; P G Canonico; F G Shirey; J S Walker
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

4.  Differences in buoyant-density properties of Coxiella burnetii and Rickettsia rickettsii.

Authors:  R F Wachter; G P Briggs; C E Pedersen
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

5.  Effect of vaccination schedule on immune response of Macaca mulatta to cell culture-grown Rocky Mountain spotted fever vaccine.

Authors:  L S Sammons; R H Kenyon; C E Pedersen
Journal:  J Clin Microbiol       Date:  1976-09       Impact factor: 5.948

6.  Comparison of three rocky mountain spotted fever vaccines.

Authors:  R H Kenyon; L S Sammons; C E Pedersen
Journal:  J Clin Microbiol       Date:  1975-10       Impact factor: 5.948

7.  Interaction between Coxiella burnetii and guinea pig peritoneal macrophages.

Authors:  R A Kishimoto; J S Walker
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

8.  Rocky Mountain spotted fever vaccine in an animal model.

Authors:  J D Folds; D H Walker; B C Hegarty; D Banasiak; J V Lange
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

9.  Identification of CD8 T-lymphocyte epitopes in OmpB of Rickettsia conorii.

Authors:  Zhen Li; C Marcela Díaz-Montero; Gustavo Valbuena; Xue-Jie Yu; Juan P Olano; Hui-Min Feng; David H Walker
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  In vitro guinea pig leukocyte reactions to Rickettsia rickettsii.

Authors:  R H Kenyon; M S Ascher; R A Kishimoto; C E Pedersen
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.